The Canadian Childhood Nephrotic Syndrome Project (CHILDNEPH) Biobank
Summary
Nephrotic syndrome is the most common acquired kidney disease in children. Affected children have massive leakage of protein into the urine as a consequence and develop body swelling (edema). Most children respond to treatment with drugs (steroids), however, many of them require repeated courses of steroids to treat the frequent relapses of the disease.
Long term steroid usage causes many side-effects including obesity, growth retardation, hypertension and cataracts.
We want to minimize steroid usage in the treatment of Nephrotic Syndrome because it is the number one priority of the patients and families. To do this, we need to figure out how this common pediatric disease occurs; so, we are collecting biological samples (blood and saliva), clinical and demographic information from children presenting with Nephrotic Syndrome. These samples and clinical information will be used by scientists to shape future Nephrotic Syndrome research and to find new ways to treat childhood Nephrotic Syndrome.
Eligibility
Eligible ages: 1 to 18
Accepts healthy participants: Yes
Inclusion criteria:
Patients between 1 - 18 years of age who present with Childhood Nephrotic Syndrome will be eligible to consent for this study.
Exclusion criteria:
Pediatric patients who have Nephrotic Syndrome due a secondary disease (i.e. lupus, cancer)
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Email: childneph@ucalgary.ca Call: 403-955-2467
Principal investigator:
Susan Samuel
Clinical trial:
No
REB-ID:
REB16-2186
External links